Distinct packing required for drug sample exemption; extended excise limitation fails without proof of suppression or wilful misstatement.

Clinical samples of medicines qualified for exemption under Notification No. 48/77-C.E. only if they were clearly marked as physician's samples and packed in a form distinctly different from regular trade packing. Minor differences in printing, price indication, or quantity were insufficient where the packs remained substantially alike; on the facts noted, the sample packs for Cemizol Vet, Sukcee Drops, and Cebexin did not meet the distinct-packing requirement, so exemption was denied and duty remained chargeable. For past clearances, the extended limitation period could not be invoked absent proof of suppression, wilful misstatement, or clandestine removal, particularly where classification lists, gate passes, and RT-12 returns had been regularly filed and approved; the demand was confined to the normal period.

---

---

Issues: (i) Whether clinical samples of the medicines satisfied Notification No. 48/77-C.E. by being packed in a form distinctly different from regular trade packing; (ii) Whether the demand for duty on past clearances could be raised for the extended period on the basis of suppression or misstatement of facts.

Issue (i): Whether clinical samples of the medicines satisfied Notification No. 48/77-C.E. by being packed in a form distinctly different from regular trade packing.

Analysis: The exemption required not only a clear and conspicuous marking that the goods were physician's samples, but also a packing form that was distinctly different from regular trade packing. Minor differences in printing, price indication, quantity indication, or similar details were held insufficient if the packs remained substantially alike in appearance and form. On comparison of the sample and trade packs, the samples of Cemizol Vet and Sukcee Drops were found not to be distinctly different in form, and in the case of Cebexin no material evidence was produced to show a distinct difference in packing.

Conclusion: The samples of Cemizol Vet, Sukcee Drops, and Cebexin were not entitled to exemption under Notification No. 48/77-C.E., and duty was chargeable.

Issue (ii): Whether the demand for duty on past clearances could be raised for the extended period on the basis of suppression or misstatement of facts.

Analysis: The record showed regular filing and approval of classification lists, clearance under gate passes, and submission of RT-12 returns. The facts necessary for verification were available to the department, and no clandestine removal, suppression of facts, or wilful misstatement was proved. In such circumstances, the longer period could not be invoked, and the demand was confined to the statutory limitation period.

Conclusion: The demand for past clearances was restricted to six months and the extended period was held inapplicable.

Final Conclusion: The exemption was denied on merits, but the duty demand was limited to the normal limitation period because the ingredients for invoking the extended period were not established.

Ratio Decidendi: For an exemption requiring packing in a form distinctly different from regular trade packing, mere labeling or minor differences in print, price, or quantity are insufficient; and the extended limitation period for central excise duty cannot be invoked without proof of suppression, wilful misstatement, or clandestine removal.

---